Treating gastrointestinal neuroendocrine tumors has long been complicated by resistance to existing therapies. Researchers at Michigan Medicine are exploring a new protein involved in tumor survival, opening up a potential new direction for how these cancers could be treated.
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.